找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cosmetics; Controlled Efficacy P. Elsner,Howard I. Maibach (Professor),Hans F. Me Book 1999 Springer-Verlag Berlin Heidelberg 1999 ageing.

[復(fù)制鏈接]
樓主: 要求
41#
發(fā)表于 2025-3-28 16:10:00 | 只看該作者
Ruth McNerlan,Yaxin Bi,Guoze Zhao,Bing Han We will provide here information about the PAL, especially about those regulations related to efficacy claims for cosmetics (We use the term of efficacy simply here; however, it can also denote clinical effectiveness, usefulness and even product claims).
42#
發(fā)表于 2025-3-28 21:45:22 | 只看該作者
43#
發(fā)表于 2025-3-28 23:18:31 | 只看該作者
44#
發(fā)表于 2025-3-29 04:43:45 | 只看該作者
45#
發(fā)表于 2025-3-29 10:43:07 | 只看該作者
to Article 7b, special claims of efficacy could be legally attributed to cosmetic products but under the obligation to make evidence of the claimed effects; also an entirely new "controller" was introduced - the independent "safety assessor", This indeed means not only progress in reliable and hones
46#
發(fā)表于 2025-3-29 15:05:48 | 只看該作者
Michael Crowhurst,Michael Emslieons for its use and disposal as well as any other indication or information provided by the manufacturer or his authorized agent or by any other person responsible for placing the product on the Community market” [1].
47#
發(fā)表于 2025-3-29 16:29:39 | 只看該作者
Zhiwei Luo,Rong Xie,Wangyi Huang,Yiwei Shann Europe, for example, the European Cosmetic Directive requires that products have documentation to support the claims made [1]. In the United States the requirement is essentially the same except that some products that are considered cosmetic in some regulatory jurisdictions are over-the-counter drug products in the United States.
48#
發(fā)表于 2025-3-29 20:16:32 | 只看該作者
Siegfried Bodenmann,Anne-Lise Reyributed to wider use. As available products have proliferated in the marketplace, claims regarding performance and efficacy of self-tanning lotions have been refined and broadened for promotion to an enlarging consumer base.
49#
發(fā)表于 2025-3-30 00:11:46 | 只看該作者
50#
發(fā)表于 2025-3-30 07:38:35 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 15:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
灵台县| 红桥区| 安陆市| 澎湖县| 九龙县| 中方县| 正安县| 绍兴县| 桓仁| 吉首市| 德格县| 文山县| 调兵山市| 渭南市| 南靖县| 奉节县| 永安市| 甘洛县| 堆龙德庆县| 中方县| 丽水市| 遂平县| 宜章县| 德庆县| 巫溪县| 敦化市| 平江县| 夏津县| 新野县| 柘荣县| 武宁县| 长寿区| 田东县| 京山县| 玉田县| 曲周县| 阿尔山市| 尚志市| 石屏县| 河南省| 修水县|